Comparison of photochemotherapy and dithranol in the treatment of chronic plaque psoriasis.

Author: BriffaD V, GreavesM, MarksJ, RogersS, ShusterS, WarinA

Paper Details 
Original Abstract of the Article :
A two-centre trial has been carried out on 224 patients with chronic plaque psoriasis randomly allocated to treatment with a standard dithranol regimen of 8-methoxypsoralen and long-wave ultraviolet light (P.U.V.A.). Lesions in 91% of the 113 in the P.U.V.A. group cleared satisfactorily compared wit...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/s0140-6736(79)90820-1

データ提供:米国国立医学図書館(NLM)

Photochemotherapy vs. Dithranol for Psoriasis: A Camel's Tale of Two Treatments

This research delves into the world of psoriasis, a skin condition as persistent as a desert sand dune. The study compares two treatments, photochemotherapy (PUVA) and dithranol, for chronic plaque psoriasis. Researchers randomly assigned 224 patients to receive one of these treatments. They found that PUVA cleared lesions in 91% of patients, while dithranol cleared lesions in 82%. However, PUVA took longer to achieve clearance. Despite the longer treatment time, PUVA was found to be more convenient and acceptable to patients. This study provides valuable insights into the effectiveness and patient preferences for these two treatment options.

PUVA: A Light at the End of the Psoriasis Tunnel

The study highlights the effectiveness of PUVA, a treatment that utilizes light therapy, in clearing psoriasis lesions. Although PUVA takes longer than dithranol, its convenience and patient acceptability make it a promising option for those seeking relief from the persistent symptoms of psoriasis. The study's findings suggest that PUVA can be a more appealing alternative for patients, especially those who struggle with the challenges of traditional treatments.

Camel's Perspective: Finding the Coolest Shade

Navigating the scorching heat of psoriasis requires finding the right shade. PUVA offers a more convenient approach than dithranol, making it a welcome oasis for patients seeking relief. It's like finding the coolest spot under a towering acacia tree in the desert.

Dr.Camel's Conclusion

This study sheds light on the benefits of PUVA in treating chronic plaque psoriasis. While PUVA requires a longer treatment period than dithranol, its convenience and patient acceptability make it a valuable option. The findings suggest that PUVA may be particularly well-suited for patients who are seeking a less disruptive and more comfortable approach to psoriasis management.

Date :
  1. Date Completed 1979-05-23
  2. Date Revised 2019-06-10
Further Info :

Pubmed ID

85052

DOI: Digital Object Identifier

10.1016/s0140-6736(79)90820-1

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.